» Articles » PMID: 22882974

Cell-surface Metalloprotease ADAM12 is Internalized by a Clathrin- and Grb2-dependent Mechanism

Overview
Journal Traffic
Publisher Wiley
Specialties Biology
Physiology
Date 2012 Aug 14
PMID 22882974
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

ADAM12 (A Disintegrin And Metalloprotease 12), a member of the ADAMs family of transmembrane proteins, is involved in ectodomain shedding, cell-adhesion and signaling, with important implications in cancer. Therefore, mechanisms that regulate the levels and activity of ADAM12 at the cell-surface are possibly crucial in these contexts. We here investigated internalization and subsequent recycling or degradation of ADAM12 as a potentially important regulatory mechanism. Our results show that ADAM12 is constitutively internalized primarily via the clathrin-dependent pathway and is subsequently detected in both early and recycling endosomes. The protease activity of ADAM12 does not influence this internalization mechanism. Analysis of essential elements for internalization established that proline-rich regions in the cytoplasmic domain of ADAM12, previously shown to interact with Src-homology 3 domains, were necessary for proper internalization. These sites in the ADAM12 cytoplasmic domain interacted with the adaptor protein growth factor receptor-bound protein 2 (Grb2) and knockdown of Grb2 markedly reduced ADAM12 internalization. These studies establish that internalization is indeed a mechanism that regulates ADAM cell surface levels and show that ADAM12 internalization involves the clathrin-dependent pathway and Grb2.

Citing Articles

An unexpected role for the conserved ADAM-family metalloprotease ADM-2 in Caenorhabditis elegans molting.

Joseph B, Edeen P, Meadows S, Binti S, Fay D PLoS Genet. 2022; 18(5):e1010249.

PMID: 35639786 PMC: 9187072. DOI: 10.1371/journal.pgen.1010249.


Interleukin-6 controls recycling and degradation, but not internalization of its receptors.

Flynn C, Kespohl B, Daunke T, Garbers Y, Dusterhoft S, Rose-John S J Biol Chem. 2021; 296:100434.

PMID: 33610555 PMC: 8010714. DOI: 10.1016/j.jbc.2021.100434.


CAMKV Is a Candidate Immunotherapeutic Target in Amplified Neuroblastoma.

Sussman R, Rokita J, Huang K, Raman P, Rathi K, Martinez D Front Oncol. 2020; 10:302.

PMID: 32211329 PMC: 7069022. DOI: 10.3389/fonc.2020.00302.


Regulation of Fibrotic Processes in the Liver by ADAM Proteases.

Schmidt-Arras D, Rose-John S Cells. 2019; 8(10).

PMID: 31601007 PMC: 6830092. DOI: 10.3390/cells8101226.


Prevention of excitotoxicity-induced processing of BDNF receptor TrkB-FL leads to stroke neuroprotection.

Tejeda G, Esteban-Ortega G, San Antonio E, Vidaurre O, Diaz-Guerra M EMBO Mol Med. 2019; 11(7):e9950.

PMID: 31273936 PMC: 6609917. DOI: 10.15252/emmm.201809950.